9 January 2023 

Kromek Group plc 

("Kromek" or the "Group") 

Kromek Secures $0.8m Order for D3S ID

Repeat order from US government customer for wearable nuclear radiation detector

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that it has secured a repeat order, worth $0.8m, from a US government customer for its D3S ID wearable nuclear radiation detector. Delivery and revenue recognition is expected to occur in the Group's current financial year.

D3S ID gamma neutron detector

The D3S ID gamma neutron detector is a wearable Radiation Isotope Identifier ("RIID") designed for first responders, armed forces, border security and other CBRN experts. Unlike a conventional RIID, it is a pocket-sized device and is small and light enough to be wearable and concealable. It can recognise isotopes and neutrons in seconds and is designed to detect radiological threats like dirty bombs, radioactive contamination, smuggling of radioactive substances and radiation at the scene of an accident or terrorist attack.

Arnab Basu, CEO of Kromek Group, said: "This repeat order affirms the importance of our nuclear radiation detection technology and the strength of our relationship with our US governmental customers. We are continuing to see heightened interest in our CBRN solutions, particularly from governments, and expect this momentum to be sustained given the ongoing challenges in the geopolitical environment."

ENDS

For further information, please contact: 

Kromek Group plc 

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.  

The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.  

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of 'dirty bombs'.  

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.  

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.  

Further information is available at www.kromek.com.